Citations
75 citation(s) found for "Goadsby, Peter J".
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng
Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available
A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)
Starling, Amaal J. , Tepper, Stewart J. , Shamim, Ejaz A. , Hindiyeh, Nada , Silberstein, Stephen D., Marmura, Michael J. , Robbins, Matthew S. , Charles, Andrew , Goadsby, Peter J. , Lipton, Richard B. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Dodick, David W. , Goadsby, Peter J. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Cady, Roger, Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)
Silberstein, Stephen D., Zhang, Feng, Xue, Fei , Cheng, Sunfa , Chou, Denise E. , Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng, Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Exploring the Boundaries Between Episodic and Chronic Migraine: Results from the CaMEO Study (502)
Adams, Aubrey Manack, Reed, Michael L. , Fanning, Kristina M. , Buse, Dawn C. , Goadsby, Peter J. , Olesen, Jes , Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Ubrogepant is Effective in the Acute Treatment of Migraine with Mild Pain (4726)
Adams, Aubrey Manack, Lai, Jeff, Yu, Sung Yun , Finnegan, Michelle , Trugman, Joel M. , Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J. , Burstein, Rami
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Ubrogepant Achieves Onset of Pain Relief at 1 Hour for the Acute Treatment of Migraine (1223)
Lu, Kaifeng , Jakate, Abhijeet , Finnegan, Michelle , Szegedi, Armin, Trugman, Joel M. , Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Cardiovascular Safety of Erenumab in Patients with Migraine and Aura (1209)
Tepper, Stewart J. , Xue, Fei , Olearczyk, J, Ashina, Messoud , Goadsby, Peter J. , Dodick, David W. , Zhang, Feng , Olearczyk, Jeffrey, Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available